We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology

News   Mar 30, 2012

 
Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology
 
 
Advertisement
 

RELATED ARTICLES

Success in Use of Nanoparticles To Deliver Gene Therapy for Eye Disease in Rodents

News

In experiments in rats and mice, scientists report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

READ MORE

Computer Model Helps Improve Injectability of Drug-delivering Particles

News

Researchers have developed a computational model that helps improve the injectability of microparticles and prevent them from clogging.

READ MORE

Artificial Genes Sense Cellular Responses to Drugs

News

BUSM researchers have developed and implemented a new way to better understand how human cells communicate with each other, how this communication is disrupted in human diseases and how this can be corrected pharmacologically.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE